Skip to main content
SPT logo

SPT — Investor Relations & Filings

Ticker · 1789 ISIN · TW0001789006 TW Manufacturing
Open in API
Filings indexed 2,231 across all filing types
Latest filing 2023-11-07 Director's Dealing
Country TW Taiwan
Listing TW 1789

About SPT

https://www.scinopharm.com/tw

ScinoPharm Taiwan, Ltd. is a global provider of high-quality Active Pharmaceutical Ingredients (APIs) and comprehensive Contract Development and Manufacturing Organization (CDMO) services. The company specializes in process research, development, and cGMP production, maintaining a leadership position in oncology APIs. Its portfolio covers therapeutic areas including cancer, hematology, metabolic disorders, and central nervous system diseases. ScinoPharm offers one-stop solutions encompassing peptide synthesis, API process development, and the manufacturing of sterile injectables and complex generics. The company is distinguished by its expertise in high-barrier pharmaceutical technologies and adherence to stringent international regulatory standards, such as the U.S. FDA. Serving both generic and innovative drug sectors, it leverages advanced R&D and integrated manufacturing to support global healthcare markets.

Recent filings

Filing Released Lang Actions
112年10月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, their representatives, spouses, and minor children. It provides data on stock types, quantities held at appointment, changes during the month, and current holdings. The content focuses on insider share ownership and transactions, without financial statements, earnings data, or management commentary. There is no indication of an annual report, earnings release, or other financial report. The document is not a proxy solicitation or voting result announcement. It is a report of personal share transactions and holdings by company directors and executives, fitting the definition of Director's Dealing (DIRS). The document length is substantial and contains actual data, not just an announcement or certification.
2023-11-07 Chinese
112年10月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and senior management, showing their current holdings, pledged shares, and related information. It is focused on insider shareholdings and does not contain financial statements, earnings data, or management discussion. The content aligns with reporting of insider share transactions or holdings. There is no indication of a full annual or quarterly report, audit report, or earnings release. The document is not a proxy statement or AGM material. Given the detailed insider shareholding data, this fits best with the category of Director's Dealing (DIRS), which covers reports of personal share transactions or holdings by company directors and executives.
2023-11-07 Chinese
公告本公司法人董事改派代表人
Board/Management Information Classification · 100% confidence The document is a short announcement (673 characters) about a change in the company's board representation, specifically the appointment of a new representative director from a corporate shareholder. It includes details such as the old and new representative names, their positions, and effective dates. There is no financial data, no mention of financial results, reports, or regulatory filings beyond this management change. The content fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2023-11-03 Chinese
112年9月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 神隆, providing information about loan balances and endorsement guarantees for the current and previous months. It contains tabular data on financial guarantees and limits but does not include comprehensive financial statements or detailed analysis. The document length is very short (624 characters), and it appears to be a regulatory disclosure rather than a full report. There is no indication of it being an annual or interim report, audit report, or any other detailed filing. It fits best as a general regulatory announcement or compliance disclosure, which aligns with the Regulatory Filings (RNS) category as a fallback for miscellaneous filings that do not fit other categories.
2023-10-06 Chinese
112年9月營業收入
Regulatory Filings Classification · 95% confidence The document is a revenue summary report from a listed company, showing monthly and cumulative net operating revenue figures with comparisons to the previous year. It includes notes on accounting standards (IFRS) and reporting practices. The document length is short (774 characters) and it primarily provides summarized financial data without detailed financial statements or management discussion. It does not appear to be a full annual or interim report, nor an earnings release with highlights. It is a regulatory disclosure of financial data, typical of a Regulatory Filing (RNS) in this context, as it does not fit the criteria for other more specific categories like Annual Report, Interim Report, or Earnings Release.
2023-10-06 Chinese
112年09月內部人持股異動(事後)
Major Shareholding Notification Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, independent directors, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares. The content is focused on insider shareholding disclosures rather than financial results, management changes, or other corporate events. There is no indication of an annual report, earnings release, or other financial report. The document is a notification of insider shareholdings, which aligns with the category of Major Shareholding Notification (MRQ). The document length is substantial and contains actual data, not just an announcement or certification, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA). Therefore, the best classification is MRQ.
2023-10-04 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.